The post Billionaire Kwek Leng Beng’s CDL Sells 84% Of Residential Towers Amid Singapore Property Boom appeared on BitcoinEthereumNews.com. Buyers looking at the Zyon Grand sales gallery over the weekend launch. Courtesy of City Developments City Developments Ltd. (CDL)—controlled by billionaire Kwek Leng Beng and his family—has sold 84% of an upscale residential skyscraper near the Singapore central business district over the weekend, adding to signs the property boom in the city-state is continuing. The Singapore-listed property developer sold 590 units of the 706-unit Zyon Grand twin 62-story residential towers at an average selling price of S$3,050 ($2,351) per square foot, CDL said in a statement over the weekend. The company is jointly developing the project with Japan’s Mitsui Fudosan along Zion Road, near the Orchard Road shopping district. “As one of the largest projects launched this year, the positive take-up reflects the market’s confidence in this landmark integrated development and the genuine demand for distinctive homes in a sought-after neighbourhood,” Sherman Kwek, group CEO of City Developments, said in the statement. Zyon Grand is part of an integrated development that features restaurants, a supermarket, and early childhood care center and a 36-story tower that houses Singapore’s first long-stay serviced apartment complex. The project is one of several prime residential condominium projects that have seen brisk sales in recent weeks. Earlier this month, Billionaire Quek Leng Chan’s GuocoLand sold 86% of the 399-unit Faber Residence in the western Singapore town of Clementi, while UOL Group—controlled by the family of late banking tycoon Wee Cho Yaw—and partner CapitaLand Development have sold nearly all the units at the 666-unit Skye at Holland—an upscale condominium project in the expatriate enclave of Holland Village. Singapore home prices rose for the fourth consecutive quarter in the three months ended September as declining domestic lending rates and an influx of wealthy foreign residents bolstered demand. Prices of private residential properties climbed 0.9% in the third… The post Billionaire Kwek Leng Beng’s CDL Sells 84% Of Residential Towers Amid Singapore Property Boom appeared on BitcoinEthereumNews.com. Buyers looking at the Zyon Grand sales gallery over the weekend launch. Courtesy of City Developments City Developments Ltd. (CDL)—controlled by billionaire Kwek Leng Beng and his family—has sold 84% of an upscale residential skyscraper near the Singapore central business district over the weekend, adding to signs the property boom in the city-state is continuing. The Singapore-listed property developer sold 590 units of the 706-unit Zyon Grand twin 62-story residential towers at an average selling price of S$3,050 ($2,351) per square foot, CDL said in a statement over the weekend. The company is jointly developing the project with Japan’s Mitsui Fudosan along Zion Road, near the Orchard Road shopping district. “As one of the largest projects launched this year, the positive take-up reflects the market’s confidence in this landmark integrated development and the genuine demand for distinctive homes in a sought-after neighbourhood,” Sherman Kwek, group CEO of City Developments, said in the statement. Zyon Grand is part of an integrated development that features restaurants, a supermarket, and early childhood care center and a 36-story tower that houses Singapore’s first long-stay serviced apartment complex. The project is one of several prime residential condominium projects that have seen brisk sales in recent weeks. Earlier this month, Billionaire Quek Leng Chan’s GuocoLand sold 86% of the 399-unit Faber Residence in the western Singapore town of Clementi, while UOL Group—controlled by the family of late banking tycoon Wee Cho Yaw—and partner CapitaLand Development have sold nearly all the units at the 666-unit Skye at Holland—an upscale condominium project in the expatriate enclave of Holland Village. Singapore home prices rose for the fourth consecutive quarter in the three months ended September as declining domestic lending rates and an influx of wealthy foreign residents bolstered demand. Prices of private residential properties climbed 0.9% in the third…

Billionaire Kwek Leng Beng’s CDL Sells 84% Of Residential Towers Amid Singapore Property Boom

Buyers looking at the Zyon Grand sales gallery over the weekend launch.

Courtesy of City Developments

City Developments Ltd. (CDL)—controlled by billionaire Kwek Leng Beng and his family—has sold 84% of an upscale residential skyscraper near the Singapore central business district over the weekend, adding to signs the property boom in the city-state is continuing.

The Singapore-listed property developer sold 590 units of the 706-unit Zyon Grand twin 62-story residential towers at an average selling price of S$3,050 ($2,351) per square foot, CDL said in a statement over the weekend. The company is jointly developing the project with Japan’s Mitsui Fudosan along Zion Road, near the Orchard Road shopping district.

“As one of the largest projects launched this year, the positive take-up reflects the market’s confidence in this landmark integrated development and the genuine demand for distinctive homes in a sought-after neighbourhood,” Sherman Kwek, group CEO of City Developments, said in the statement.

Zyon Grand is part of an integrated development that features restaurants, a supermarket, and early childhood care center and a 36-story tower that houses Singapore’s first long-stay serviced apartment complex.

The project is one of several prime residential condominium projects that have seen brisk sales in recent weeks. Earlier this month, Billionaire Quek Leng Chan’s GuocoLand sold 86% of the 399-unit Faber Residence in the western Singapore town of Clementi, while UOL Group—controlled by the family of late banking tycoon Wee Cho Yaw—and partner CapitaLand Development have sold nearly all the units at the 666-unit Skye at Holland—an upscale condominium project in the expatriate enclave of Holland Village.

Singapore home prices rose for the fourth consecutive quarter in the three months ended September as declining domestic lending rates and an influx of wealthy foreign residents bolstered demand. Prices of private residential properties climbed 0.9% in the third quarter from the previous three months, according to data released by the Urban Redevelopment Authority on Friday.

“New citizens and permanent residents who favor high-rise living have been acquiring homes in a stable Singapore, against the backdrop of a destabilising global environment,” Leonard Tay, Singapore-based research head of British property consultancy Knight Frank, said by email. He noted that the city-state welcomed 22,766 new citizens and 35,264 new permanent residents in 2024.

Source: https://www.forbes.com/sites/jonathanburgos/2025/10/27/billionaire-kwek-leng-bengs-cdl-sells-84-of–residential-towers-amid-singapore-property-boom/

Market Opportunity
Creditlink Logo
Creditlink Price(CDL)
$0.02268
$0.02268$0.02268
-6.82%
USD
Creditlink (CDL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26